A 1 Month Randomized Placebo Controlled, Double Blind Trial With a 5 Month Open Extension Phase to Explore the Efficacy of Zonisamide on Apnea/Hypopnea Index in Overweight/Obese Sleep Apnea Patients.

Trial Profile

A 1 Month Randomized Placebo Controlled, Double Blind Trial With a 5 Month Open Extension Phase to Explore the Efficacy of Zonisamide on Apnea/Hypopnea Index in Overweight/Obese Sleep Apnea Patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Apr 2014

At a glance

  • Drugs Zonisamide (Primary)
  • Indications Obesity; Sleep apnoea syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Nov 2013 Status changed from active, no longer recruiting to completed.
    • 10 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.
    • 24 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top